Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors

Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified. Now scientists at Duke Cancer Institute have identified mutations for the vast majority of the remaining 20 percent of...

Patient’s Advice: Nourish The Soul     

Nadine Tolman takes a sip of water from a plastic cup that her husband, Fay, has just brought her from the refreshment station. “Remember, you need to stay hydrated,” he says softly, laying his hand on her shoulder, “and don’t forget to eat your lunch.” The gentle gesture from her husband disrupts...

Tests Identify When Advanced Prostate Cancer Therapies Would Benefit

Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute. The blood tests, dubbed “liquid biopsies”, detect...

LeBlanc And Abernethy Patient-Care Paper Recognized

A journal article by hematologic oncologist, palliative care physician, and associate professor of medicine Thomas LeBlanc, MD , and adjunct professor of medicine Amy Abernethy, MD, PhD , has been recognized as a paper that could " Change the World, One Article At A Time " by Springer Nature...

Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer

Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who participated in clinical trials. In a study presented...

Black Patients Show Stronger Response to Hormone Therapy for Prostate Cancer

African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers. While median survival was similar for both black and white participants in the study, the findings...

Wei Receives $200,000 Grant For Lung Cancer Research

In partnership, Lung Cancer Initiative of North Carolina and The V Foundation for Cancer Research have awarded a $200,000 grant to Qingyi Wei , MD, PhD, Duke Cancer Institute. The grant funds research on disparities among African-Americans, with a focus on lung cancer patients in North Carolina...

Bone Scan Software Accurately Calculates Prognosis of Advanced Prostate Cancer

andrewarmstrong.jpg A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time. The software, called the automated bone scan...

Myeloma Specialist To Pedal Across England And France

Cristina Gasparetto , MD, hematologic malignancies and cellular therapy specialist, has signed on to participate in the road to Victories London to Paris Ride, a challenge event supporting the Multiple Myeloma Research Foundation’s (MMRF) mission to fund myeloma research leading to better...

Deadly Cancers Show Early, Detectable Differences from Benign Tumors

Do metastatic cancer tumors “break bad” or are they “born bad”? This question is an essential mystery in cancer early detection and treatment. Lacking a clear answer, patients are given the same aggressive therapies when small, abnormal clusters of cells are discovered early, even though they might...

New Advances in Overcoming Prostate Cancer Disparities

African American men are nearly two times more likely to develop prostate cancer than white men and nearly three times more likely to die from the disease. In North Carolina, the rate of prostate cancer-related deaths among African Americans is higher than the national average. Researchers at the...

May Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured in the media and academic journals this month. This list includes John Sampson, MD, PhD; Daniel George, MD; Angeles Alvarez Secord, MD; Ravi Bellamkonda, PhD; and many others.

Pages